Subscribe to Newsletter

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Content by Stephanie Vine:

Manufacture Advanced Medicine

Characterizing CAR T Cells

| Stephanie Vine | 2 min read

Researchers develop new approach that could help with CAR T manufacturing.

Business & Regulation Standards & Regulation

This Week’s Biopharma News: EU Launches Initiative to Attract Scientists from US

| Stephanie Vine | 4 min read

Our latest news roundup reports on Novartis’ new acquisition, an NIH grant for an Alzheimer’s disease vaccine, and more

Discovery & Development Clinical Trials

Gene Therapy Trial Helps Children with LAD-I

| Stephanie Vine | 2 min read

Gene therapy clinical trial shows striking outcomes in children with rare and often fatal immune disorder.

Discovery & Development Drug Delivery

Oral Alternatives for Injectable IV Medicines

| Stephanie Vine | 2 min read

Researchers say they have found a method that will allow some large molecules to be administered orally.

Business & Regulation Standards & Regulation

US States Sue Over RFK Jr’s HHS Layoffs and Reorganization

| Stephanie Vine | 3 min read

Attorney Generals claim: “This administration is not streamlining the federal government; they are sabotaging it.”

Discovery & Development Formulation

Tackling the Nasal Membrane Challenge

| Stephanie Vine | 3 min read

Drugs are very challenging to formulate for delivery across the nasal membrane. An expert gives their view on the issue.

Business & Regulation Profession

Starting a Business in CRISPR

| Stephanie Vine | 8 min read

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

Manufacture Clinical Trials

This Week’s Biopharma News: AstraZeneca Cans Phase III Trial

| Stephanie Vine | 3 min read

Our latest news roundup reports on Amgen’s $900 million investment, EMA’s re-examination of donanemab, philanthropy at Sanofi, and more.

Manufacture Advanced Medicine

Inhalable Gene Therapies? Here’s How They Could Work

| Stephanie Vine | 5 min read

Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.

Discovery & Development Clinical Trials

Trial Placed on FDA Clinical Hold for Testicular Toxicity

| Stephanie Vine | 1 min read

Non-clinical toxicology study of investigational drug for psoriasis reveals worrying results.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register